Tvardi Therapeutics Forecast, price target & analysts
Tvardi Therapeutics Target price 2025 - Analyst rating & recommendation
Tvardi Therapeutics Classifications & Recommendation:
Tvardi Therapeutics Price Target
| Target Price | $56.20 |
| Price | $26.11 |
| Potential |
115.24%
register free of charge
|
| Number of Estimates | 5 |
|
5 Analysts have issued a price target Tvardi Therapeutics 2026 .
The average Tvardi Therapeutics target price is $56.20.
This is
115.24%
register free of charge
$78.00
198.74%
register free of charge
$41.00
57.03%
register free of charge
|
|
| A rating was issued by 5 analysts: 5 Analysts recommend Tvardi Therapeutics to buy, 0 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Tvardi Therapeutics stock has an average upside potential 2026 of
115.24%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 7.14 | 0.65 |
| 65.95% | 90.90% | |
| Net Margin | -992.58% | -1,517.66% |
| 75.63% | 52.90% |
4 Analysts have issued a sales forecast Tvardi Therapeutics 2025 . The average Tvardi Therapeutics sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued a net profit forecast Tvardi Therapeutics 2025 . The average Tvardi Therapeutics net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Net Margin
| 2024 | -992.58% | 75.63% |
|---|---|---|
| 2025 |
-1,517.66%
52.90%
Unlock
|
|
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -46.60 | -6.49 |
| 40.86% | 86.07% | |
| P/E | negative | |
| EV/Sales | 323.37 |
1 Analysts have issued a Tvardi Therapeutics forecast for earnings per share. The average Tvardi Therapeutics EPS is
This results in the following potential growth metrics and future valuations:
Tvardi Therapeutics...
Current Tvardi Therapeutics Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Piper Sandler |
Locked
➜
Locked
|
Locked | Jun 12 2025 |
| Oppenheimer |
Locked
➜
Locked
|
Locked | May 21 2025 |
| Jones Trading |
Locked
➜
Locked
|
Locked | Apr 28 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Jun 12 2025 |
|
Locked
Oppenheimer:
Locked
➜
Locked
|
May 21 2025 |
|
Locked
Jones Trading:
Locked
➜
Locked
|
Apr 28 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
